Thrivent Financial for Lutherans’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-182,048
Closed -$2.46M 2314
2020
Q1
$2.46M Buy
182,048
+491
+0.3% +$9.32K 0.01% 865
2019
Q4
$4.39M Buy
181,557
+18,957
+12% +$393K 0.01% 769
2019
Q3
$3.13M Buy
162,600
+41,135
+34% +$942K 0.01% 809
2019
Q2
$3.59M Buy
121,465
+1,567
+1% +$60.4K 0.01% 766
2019
Q1
$5.7M Buy
119,898
+13,339
+13% +$587K 0.02% 649
2018
Q4
$3.85M Buy
106,559
+9,373
+10% +$440K 0.01% 670
2018
Q3
$5.98M Sell
97,186
-11,714
-11% -$753K 0.02% 618
2018
Q2
$7.36M Buy
108,900
+589
+0.5% +$33K 0.02% 572
2018
Q1
$5.88M Buy
108,311
+1,411
+1% +$78.9K 0.02% 614
2017
Q4
$6.39M Buy
106,900
+10,920
+11% +$662K 0.02% 577
2017
Q3
$4.67M Hold
95,980
0.02% 629
2017
Q2
$5.04M Sell
95,980
-13,150
-12% -$612K 0.02% 573
2017
Q1
$4.95M Hold
109,130
0.02% 586
2016
Q4
$4.13M Hold
109,130
0.02% 637
2016
Q3
$4.12M Buy
+109,130
New +$2.41M 0.02% 655

Other funds holding AERI

Thrivent Financial for Lutherans's AERI Position: Q2 2020 in Review

Thrivent Financial for Lutherans sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 182,048 shares — an estimated $2.46M sold.

Thrivent Financial for Lutherans first reported a position in AERI in Q3 2016 and held it in 15 quarters. The position peaked at $7.36M in Q2 2018. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Thrivent Financial for Lutherans reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 182,048 Aerie Pharmaceuticals shares in Q2 2020, an estimated $2.46M.
  • Thrivent Financial for Lutherans first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 15 quarters.
  • Thrivent Financial for Lutherans's Aerie Pharmaceuticals position peaked at $7.36M in Q2 2018.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2020, filed 12 Aug 2020.